‘Breakthrough’ Therapies: Information Requests A Sign Of Workload Problem?
Executive Summary
FDA on average sent about 20 more information requests during breakthrough product reviews than others in the Program, according to interim assessment of the PDUFA V review system. Assessment could support higher funding for breakthrough program in next user fee round.